Lax oversight around experimental stem cell therapies "can lead to bad players and bad outcomes," a new study warns. http://stanford.io/2mDtxzD pic.twitter.com/JuqTKVeXHS
11:00 AM - 17 Mar 2017
0 replies
2 retweets
15 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.